Thyroid Cancer Clinical Trials

Find Thyroid Cancer Clinical Trials Near You

Hereditary Risk Factors for Thyroid Cancer

Status: Recruiting
Location: See location...
Intervention Type: Genetic
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Thyroid cancers can occur sporadically, but can also be found as tumors that cluster in families with other cancers or genetic syndromes. Researchers are studying thyroid cancer in children and families, with a particular interest in understanding genes and other factors that may put individuals at risk for developing thyroid cancer and thyroid nodules. * In this study, family and medical history information is collected alongside a blood or saliva sample for genetic studies. * Individuals with a past or present childhood thyroid cancer/nodule or a thyroid cancer suspected to be inherited in their family are invited to participate.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

• Individual pediatric patient with current or previous known or suspected thyroid cancer or nodule(s).

• Individual adult patient with current or previous known or suspected thyroid cancer or nodule(s) if they come from a family with a high suspicion of hereditary cancer (as below).

• Individuals from families with a high suspicion of hereditary thyroid cancer:

‣ Families with a current or previous diagnosis of a thyroid cancer/nodule occurring in childhood (\<18 years old).

⁃ Families with a high suspicion of hereditary thyroid cancer/nodules other than above to include:

• Families with thyroid cancer in multiple individuals

∙ Families with thyroid cancer and a known genetic syndrome

∙ Families with thyroid cancer and a suspected genetic syndrome (e.g. multiple childhood cancers in the family, multiple primary cancers, multiple endocrinopathies, etc.)

Locations
United States
Massachusetts
Dana Farber Cancer Institute
RECRUITING
Boston
Contact Information
Primary
Junne Kamihara, MD, PhD
junne_kamihara@dfci.harvard.edu
617.632.3044
Backup
Sarah Hunt, MPH
sarah_hunt@dfci.harvard.edu
Time Frame
Start Date: 2016-03-01
Estimated Completion Date: 2029-03-01
Participants
Target number of participants: 250
Treatments
No_intervention: Lower Suspected Familial Predisposition
Lower Suspected Familial Predisposition~Screening and Enrollment:~Consent, Family HX, Medical HX, Blood/Saliva which will categorize by suspected hereditary predisposition: Based on family and medical history.~\- Sample stored in Biorepository
Experimental: Higher Suspected Familial Predisposition
Higher Suspected Familial Predisposition~Screening and Enrollment:~Consent, Family HX, Medical HX, Blood/Saliva which will categorize by suspected hereditary predisposition: Based on family and medical history.~\- Specimen Testing and Analysis~•Referral to Genetic Counselor, if indicated
Related Therapeutic Areas
Sponsors
Leads: Dana-Farber Cancer Institute

This content was sourced from clinicaltrials.gov